Predictive model of venous thromboembolism in endometrial cancer

Matsuo, Koji; Yessaian, Annie A.; Lin, Yvonne G.; Pham, Huyen Q.; Muderspach, Laila I.; Liebman, Howard A.; Morrow, C. Paul; Roman, Lynda D.

doi:10.1016/j.ygyno.2012.12.014

Cited by 55 publications

(33 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The STROBE guidelines were consulted for reporting in a case-control study [4]. Some of the patients in this study were within the context of our previous studies [20][21][22][23][24].…”

Section: Materials and Methods Eligibilitymentioning

confidence: 99%

Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer

Matsuo

Garcia‐Sayre

Medeiros

et al. 2015

Journal of Surgical Oncology

Self Cite

View full text Add to dashboard Cite

show abstract

“…The STROBE guidelines were consulted for reporting in a case-control study [4]. Some of the patients in this study were within the context of our previous studies [20][21][22][23][24].…”

Section: Materials and Methods Eligibilitymentioning

confidence: 99%

Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer

Matsuo

Garcia‐Sayre

Medeiros

et al. 2015

Journal of Surgical Oncology

Self Cite

View full text Add to dashboard Cite

show abstract

“…The STROBE guidelines were consulted for reporting in a case-control study [6]. Some cases of the study population were within the context of our previous studies [7][8][9][10][11].…”

Section: Eligibilitymentioning

confidence: 99%

Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia

Matsuo

Ramzan

Gualtieri

et al. 2015

Gynecologic Oncology

Self Cite

View full text Add to dashboard Cite

show abstract

“…A total of 9 studies comprising 1,715 patients reported the effects of pre-treatment thrombocytosis on the OS of patients with endometrial cancer (29–32,34,36–39). Considering the large heterogeneity, a random-effects model was used to summarize the 9 articles (I 2 =81.7%; P<0.001; Fig.…”

Section: Resultsmentioning

confidence: 99%

Pre‑treatment thrombocytosis predicts prognosis of endometrial cancer: A meta‑analysis of 11 studies

Xia

et al. 2019

Exp Ther Med

View full text Add to dashboard Cite

The aim of the present meta-analysis study was to determine the association between pre-treatment thrombocytosis and prognosis of patients with endometrial cancer. Articles published prior to December 2018 containing information on platelet count and endometrial cancer were searched in the PubMed, Embase and the Cochrane Library databases. A platelet count of ≥350 or >400×109/l was considered to indicate thrombocytosis. Hazard ratios (HRs) with 95% CI were calculated using a random- or fixed-effects model to assess the strength of the associations. A Funnel plot and Egger's test were used to evaluate the publication bias and sensitivity analyses were performed to estimate the robustness of the present results by using Stata 13.0 software. A pooled analysis of 11 studies that met the inclusion criteria was performed, involving a total of 2,590 patients with endometrial cancer. The overall survival (OS), progression-free survival (PFS) and disease-free survival (DFS) time of patients with endometrial cancer who exhibited pre-treatment thrombocytosis were shorter than those in patients without pre-treatment thrombocytosis (OS, HR=2.25, 95% CI=1.26–4.00; PFS, HR=2.60, 95% CI=1.23–5.50; DFS, HR=2.23, 95% CI=1.45–3.42). However, pre-treatment thrombocytosis was not associated with disease-specific survival time in patients with endometrial cancer (HR=2.17, 95% CI=0.51–9.27; P=0.296). Subgroup analysis indicated that pre-treatment thrombocytosis was not associated with OS time in patients of Asian and European ethnicity. Furthermore, pre-treatment thrombocytosis (platelet count >400×109/l) was an independent predictor of OS, PFS and DFS regardless of the clinical stage.

show abstract

Predictive model of venous thromboembolism in endometrial cancer

Cited by 55 publications

References 30 publications

Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer

Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer

Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia

Pre‑treatment thrombocytosis predicts prognosis of endometrial cancer: A meta‑analysis of 11 studies

Contact Info

Product

Resources

About